Wuhan Dazhong Dental Medical Co., Ltd. (HKG:2651)
Hong Kong · Delayed Price · Currency is HKD 15.06
+0.58 (4.01%)
At close: Aug 1, 2025, 4:00 PM HKT
Ligand Pharmaceuticals Revenue
In the year 2024, Wuhan Dazhong Dental Medical had annual revenue of 407.08M CNY, down -7.87%. Wuhan Dazhong Dental Medical had revenue of 60.28M in the half year ending June 30, 2017, with 150.15% growth.
Revenue
407.08M CNY
Revenue Growth
+335.42%
P/S Ratio
1.71
Revenue / Employee
349.73K CNY
Employees
1,164
Market Cap
741.67M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 407.08M | -34.76M | -7.87% |
| Dec 31, 2023 | 441.84M | 32.40M | 7.91% |
| Dec 31, 2022 | 409.44M | 328.26M | 404.37% |
| Dec 31, 2016 | 81.18M | 22.93M | 39.35% |
| Dec 31, 2015 | 58.25M | 23.47M | 67.48% |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |